263 related articles for article (PubMed ID: 2983024)
21. Effects of Ca2+ and calmodulin on cyclic nucleotide metabolism in neurosecretosomes isolated from ox neurohypophyses.
Dartt DA; Torp-Pedersen C; Thorn NA
Brain Res; 1981 Jan; 204(1):121-8. PubMed ID: 6113872
[TBL] [Abstract][Full Text] [Related]
22. "cAMP-specific" phosphodiesterase contributes to cGMP degradation in cerebellar cells exposed to nitric oxide.
Bellamy TC; Garthwaite J
Mol Pharmacol; 2001 Jan; 59(1):54-61. PubMed ID: 11125024
[TBL] [Abstract][Full Text] [Related]
23. Cyclic nucleotide metabolism in solid tumor tissues.
Criss WE; Muganda P; Sahai A; Morris HP
Adv Exp Med Biol; 1977 May 22-24; 92():489-516. PubMed ID: 24989
[TBL] [Abstract][Full Text] [Related]
24. Binding of L-[3H]glutamate to fresh or frozen synaptic membrane and postsynaptic density fractions isolated from cerebral cortex and cerebellum of fresh or frozen canine brain.
Wu K; Carlin R; Siekevitz P
J Neurochem; 1986 Mar; 46(3):831-41. PubMed ID: 2869103
[TBL] [Abstract][Full Text] [Related]
25. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
Torphy TJ; Zhou HL; Burman M; Huang LB
Mol Pharmacol; 1991 Mar; 39(3):376-84. PubMed ID: 1848659
[TBL] [Abstract][Full Text] [Related]
26. Age-induced differentiation of morphine's effect on cyclic nucleotide metabolism.
Hoskins B; Ho IK
Neurobiol Aging; 1987; 8(5):473-6. PubMed ID: 2891056
[TBL] [Abstract][Full Text] [Related]
27. Cyclic AMP and cyclic GMP phosphodiesterase inhibition by an antiplatelet agent, 6-[(3-methylene-2-oxo-5-phenyl-5-tetrahydrofuranyl)methoxy)quinol inone (CCT-62).
Liao CH; Tzeng CC; Teng CM
Eur J Pharmacol; 1998 May; 349(1):107-14. PubMed ID: 9669503
[TBL] [Abstract][Full Text] [Related]
28. Characterization of Na+-independent GABA and flunitrazepam binding sites in preparations of synaptic membranes and postsynaptic densities isolated from canine cerebral cortex and cerebellum.
Carlin RK; Siekevitz P
J Neurochem; 1984 Oct; 43(4):1011-7. PubMed ID: 6088689
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the soluble cyclic nucleotide phosphodiesterases in Xenopus laevis oocytes. Evidence for a calmodulin-dependent enzyme.
Miot F; Erneux C
Biochim Biophys Acta; 1982 Feb; 701(2):253-9. PubMed ID: 6280770
[TBL] [Abstract][Full Text] [Related]
30. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
Souness JE; Diocee BK; Martin W; Moodie SA
Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604
[TBL] [Abstract][Full Text] [Related]
31. Ethanol-induced changes in activities of adenylate cyclase, guanylate cyclase and cyclic adenosine 3',5'-monophosphate dependent protein kinase in the brain and liver.
Kuriyama K
Drug Alcohol Depend; 1977; 2(5-6):335-48. PubMed ID: 21064
[No Abstract] [Full Text] [Related]
32. Characterization of protein kinase C activities in postsynaptic density fractions prepared from cerebral cortex, hippocampus, and cerebellum.
Suzuki T; Okumura-Noji K; Tanaka R; Ogura A; Nakamura K; Kudo Y; Tada T
Brain Res; 1993 Aug; 619(1-2):69-75. PubMed ID: 8374793
[TBL] [Abstract][Full Text] [Related]
33. P400 protein is one of the major substrates for Ca2+/calmodulin-dependent protein kinase II in the postsynaptic density-enriched fraction isolated from rat cerebral cortex, hippocampus and cerebellum.
Suzuki T; Abe-Dohmae S; Tanaka R
Neurochem Int; 1992 Jan; 20(1):61-7. PubMed ID: 1338970
[TBL] [Abstract][Full Text] [Related]
34. Adenylate cyclase and cyclic nucleotide phosphodiesterases in the developing rat liver.
Sicard RE; Aprille JR
Biochim Biophys Acta; 1977 Dec; 500(2):235-45. PubMed ID: 201294
[No Abstract] [Full Text] [Related]
35. Dissimilar cyclic nucleotide phosphodiesterase activities in subcellular fractions from normal and SV40-transformed WI-38 fibroblasts.
Nemecek GM; Butcher RW
J Cyclic Nucleotide Res; 1979 Dec; 5(6):449-61. PubMed ID: 94064
[TBL] [Abstract][Full Text] [Related]
36. Biochemical characterization of postsynaptically localized cyclic nucleotide phosphodiesterase.
Ariano MA; Appleman MM
Brain Res; 1979 Nov; 177(2):301-9. PubMed ID: 227534
[TBL] [Abstract][Full Text] [Related]
37. The response of cyclic 3',5'-AMP and cyclic 3',5'-GMP phosphodiesterases to experimental diabetes.
Perez de Gracia B; Rhoads AR; West WL
Experientia; 1980 Jul; 36(7):824-5. PubMed ID: 6249634
[TBL] [Abstract][Full Text] [Related]
38. 3':5'-cyclic-nucleotide phosphodiesterase in the bovine pituitary gland.
Nagasaka A; Ohkubo S; Hidaka H
Biochim Biophys Acta; 1983 Feb; 755(3):481-7. PubMed ID: 6297613
[TBL] [Abstract][Full Text] [Related]
39. Components of purified sarcolemma from porcine skeletal muscle.
Mickelson JR; Louis CF
Arch Biochem Biophys; 1985 Oct; 242(1):112-26. PubMed ID: 2996426
[TBL] [Abstract][Full Text] [Related]
40. Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics.
Weishaar RE; Quade MM; Schenden JA; Evans DB
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(6):551-64. PubMed ID: 3003170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
